01 Development of Antimicrobial Catheter Coatings to Limit Device Related InfectionsThe central venous catheter market analysis shows a shift toward catheter surfaces with antimicrobial agents that help reduce microbial colonization. Coatings with chlorhexidine or silver-based compounds aim to inhibit microbial growth on catheter surfaces. These technologies address catheter infection prevention, especially in intensive care and long-term vascular access management settings.
02 Expansion of Tunneled and Implantable Catheter Designs for Long-Term Vascular AccessCentral venous catheter manufacturers are refining tunneled catheters and implantable ports for patients who require repeated or prolonged vascular access. These devices place the access point beneath the skin or route the catheter through a subcutaneous tunnel, depending on the design.
01 Supply chain disruptions are expected to have a high impact on the central venous catheter market share due to its direct exposure to shortages of medical-grade polymers, catheter tubing, and specialized coatings. A capacity-constrained recovery is likely, as strict quality requirements can delay production. Supply chain constraints could reduce the growth rate from 6.38% to 4.88%, a decline of 1.50 percentage points. As supply conditions normalize, the central venous catheter market growth is expected to gradually return to 6.38%.
01 The central venous catheter market forecasts investment in catheter manufacturing, vascular access monitoring technologies, and devices designed to improve catheter placement and patient safety. In July 2026, Navi Medical Technologies completed a capital raise of AUD 6.8 million to support the US commercialization of its Neonav technology.
01 Demand for Safer Catheter Securement and Need for Multi-Lumen Catheters in Complex Treatments Drives MarketHealthcare providers are placing greater emphasis on secure catheter placement and proper maintenance to reduce complications during treatment. Advanced securement devices and catheter care systems help prevent accidental displacement, support site stability, and lower the risk of catheter-related infections. These benefits encourage hospitals to adopt improved catheter management solutions and support market demand.Patients who require several medications, fluids, or therapies at the same time often need reliable vascular access. Multi-lumen catheters allow healthcare professionals to deliver different treatments through separate channels, reducing the need for multiple vascular access devices.
01 Catheter Placement Complexity and Material-Related Complications Restrain Market ExpansionCentral venous catheter placement requires precise access to large blood vessels and careful positioning to avoid complications. Difficult insertion procedures can increase the risk of vessel injury, incorrect catheter placement, and pneumothorax, which may limit the use of these devices in certain clinical settings.Some catheter materials can cause allergic reactions or fail to provide suitable durability under repeated clinical use. Material incompatibility and catheter damage can require device replacement or alternative product selection, increasing treatment costs.
01 Development of Central Venous Catheters for Extracorporeal Photopheresis and Remote Patient Monitoring Create Opportunities for Market PlayersExtracorporeal photopheresis provides a specialized opportunity for central venous catheter manufacturers. This therapy requires reliable vascular access for blood collection and return during treatment. Manufacturers can develop catheters with suitable flow capacity and lumen configurations for patients who undergo repeated photopheresis sessions.Remote patient monitoring offers another niche opportunity through central venous catheter systems with sensors or compatible accessories that help detect changes in catheter function. These solutions could support earlier identification of flow problems or pressure changes in selected care settings. Medical device companies can collaborate with monitoring technology developers to assess safe, clinically validated applications for long-term vascular access care.
July 2026 Teleflex secured a national purchasing agreement with Premier, expanding access to its Arrow-brand central venous catheters.
June 2026 BD’s CentroVena One Insertion System received an Innovative Technology contract from Vizient.
April 2026 Becton, Dickinson and Company commercially launched the CentroVena One Insertion System in the United States.